ANN is more a 50% healthcare and 50% industrial stock, which we see as a wait-and-see situation after making a recent acquisition, although the stock has been edging higher through 2024. The market’s success rate at integrating takeovers leaves a lot to be desired, and we feel comfortable being observers of ANN.
- We can see ANN testing $30 into Christmas, but it’s not one for us.
MM is neutral to cautiously bullish towards ANN
Add To Hit List
